Mumbai, INDIA
+91 22-2581-7000
+91 22-2581-7002

FEMIPRISTAL

THE FIRST ORAL NON-INVASIVE LONG TERM TREATMENT OPTION FOR UTERINE FIBROID

 

Ulipristal acetate is a potent Anti-progesterone which acts on
• Fibroids
• Inhibition of cell proliferation
• Induction of apoptosis
• Reduces fibroid size
• Endometrium
• Stops uterine bleeding
• Results in benign and reversible changes
• Results in amenorrhea
• Pituitary HPO Axis
• Decreases LH & FSH
• Maintaining mid-follicular phase levels of estradiol (60-150 pg/ml)
• Inhibits ovulation

TRANSFORMING THE MANAGEMENT OF UTERINE FIBROID WITH LONG-TERM USE OF FEMIPRISTAL
Femipristal provides:
• Fast, reliable and sustained bleeding control
• Significant and sustained reductions in fibroid volume
• Improved quality of life, to the level of healthy subjects
• Efficacy on fibroid and associated symptom maintenance during off-treatment periods
• Safe treatment for long-term symptom management – repeated treatment courses did not increase the occurrence of adverse events

Esmya® Femipristal is an oral Selective Progesterone Receptor Modulator (SPRM) specifically designed to treat symptoms of uterine fibroids.

Ulipristal acetate (5mg)

1×10 Capsules

• Long term Intermittent treatment of moderate to severe symptoms of Uterine Fibroid in adult women of reproductive age
• Preoperative treatment of moderate to severe symptoms of Uterine Fibroid in adult women of reproductive age

Related Posts